 Medulloblastoma freedom relapse years therapeutic cure Seventy-seven patients medulloblastoma Stanford University Medical Center Multimodality therapy utilized surgical extirpation megavoltage irradiation cases chemotherapy adjunctive treatment actuarial survival rates maximum follow-up period median years treatment failures years tumor-free survival Gross total removal tumor patients surgical mortality rate significant difference incidence metastatic disease patients classical form medulloblastoma present cases desmoplastic subtype Survival rates patients desmoplastic tumors patients high-dose irradiation equal cGy posterior fossa early data freedom relapse possible beneficial effect chemotherapy long-term follow-up results advantage modality treatment patterns relapse survival relapses central nervous system Collins rule applicable cases period risk patients recurrent disease none long-term survivors study data freedom relapse years diagnosis cure disease Long-term follow-up monitoring essential efficacy treatment survival patterns